VF
SGMO

Virtu Financial’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Virtu Financial’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-132,356
Closed -$56K – 2236
2025
Q4 		$56K Buy
+132,356
New +$70.2K ﹤0.01% 1289
2025
Q3 		– Sell
-187,395
Closed -$101K – 2022
2025
Q2 		$101K Buy
+187,395
New +$111K 0.01% 1040
2024
Q4 		– Sell
-172,665
Closed -$150K – 2003
2024
Q3 		$150K Buy
+172,665
New +$126K 0.01% 851
2023
Q3 		– Sell
-17,264
Closed -$22K – 1831
2023
Q2 		$22K Buy
+17,264
New +$23.6K ﹤0.01% 1246
2023
Q1 		– Sell
-24,880
Closed -$78K – 2041
2022
Q4 		$78K Buy
+24,880
New +$96.6K 0.01% 1010
2022
Q1 		– Sell
-15,176
Closed -$114K – 1977
2021
Q4 		$114K Buy
+15,176
New +$132K 0.01% 1075
2021
Q1 		– Sell
-13,543
Closed -$211K – 1983
2020
Q4 		$211K Sell
13,543
-7,689
-36% -$90.1K 0.02% 828
2020
Q3 		$201K Sell
21,232
-28,194
-57% -$305K 0.03% 593
2020
Q2 		$443K Buy
+49,426
New +$459K 0.05% 410
2019
Q4 		$105K Sell
12,548
-44,212
-78% -$407K 0.01% 1074
2019
Q3 		$514K Buy
+56,760
New +$637K 0.04% 504
2019
Q2 		– Sell
-25,430
Closed -$243K – 1810
2019
Q1 		$243K Buy
25,430
+14,215
+127% +$145K 0.01% 896
2018
Q4 		$129K Buy
+11,215
New +$139K 0.01% 1069
2018
Q3 		– Sell
-16,662
Closed -$237K – 2106
2018
Q2 		$237K Sell
16,662
-21,622
-56% -$359K 0.01% 1365
2018
Q1 		$727K Buy
+38,284
New +$818K 0.04% 509

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Virtu Financial's SGMO Position: Q1 2026 in Review

Virtu Financial sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026, closing a stake of 132,356 shares — an estimated $56K sold.

Virtu Financial first reported a position in SGMO in Q1 2018 and held it in 15 quarters. The position peaked at $727K in Q1 2018. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Virtu Financial reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 132,356 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $56K.
  • Virtu Financial first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and held it in 15 quarters.
  • Virtu Financial's SANGAMO THERAPEUTICS INC position peaked at $727K in Q1 2018.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.